2m 2m 2m 2m 2m 2m 2m
Incyte (INCY)
NASDAQ
$118.85-$0.67 (-0.56%)
Price as of Jul 31, 2026 7:59 PM EDT- $24.2BMarket Cap
- 58.12%1-Year Change
- BiotechnologyIndustry
Incyte (INCY)
$118.85-$0.67 (-0.56%)
INCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $119.52 | ||
Change | -$3.47 (-2.82%) | ||
Open | $122.75 | ||
High | $122.75 | ||
Low | $118.44 | ||
Previous Close | $122.99 | ||
Volume | 1,829,492 | ||
30-Day Average Volume | 1,929,552 | ||
1-Week Change | 1.57% | ||
1-Month Change | 5.43% | ||
1-Year Change | 58.12% | ||
3-Year Change | 87.57% | ||
5-Year Change | 54.52% | ||
Fundamentals | |||
Shares Outstanding | 202.7M | ||
Total Assets | $7.9B | ||
Market Cap | $24.2B | ||
Enterprise Value | $20.2B | ||
Period: QTR TTM FY | |||
Revenue | $1.5B | ||
Net Income | $585.6M | ||
Free Cash Flow | $507.7M | ||
EBIT | $751.5M | ||
EBITDA | $778.0M | ||
Net Working Capital | $4.7B | ||
EPS | $2.81 | ||
Enterprise Value/EBITDA | 26 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 4 | ||
P/E | 43 | ||
PEG | 0 | ||
Price/Free Cash Flow | 48 | ||
Price/Operating Cash Flow | 48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue